ClinicalTrials.gg
RecruitingNCT07868198CORPALUpdated Oct 9, 2026

Factors Influencing Corneal Donation in Palliative Care Unit

An observational study in Corneal Transplantation, Corneal Diseases and Corneal Donation, sponsored by Groupe Hospitalier Diaconesses Croix Saint-Simon. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Groupe Hospitalier Diaconesses Croix Saint-Simon · Observational

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 7 months later.
Updated Oct 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

Today, there is a shortage of tissues such as corneas for a variety of reasons. However, it is possible to harvest tissues from people who are usually excluded from donation, particularly cancer diagnosed, by recruiting them into palliative care units.

Corneal transplantation is a surgical procedure designed to improve the vision of many persons. A number of diseases now require corneal transplants, such as keratoconus.

As with other organs, the shortage of donors remains a major obstacle to the use of this technique, a shortage which became much more acute during the health crisis linked to the pandemic caused by the SARS-CoV-2 virus. In 2022, 10615 participants were waiting for a transplant, but only 46.3% of them received one.

Cornea removal differs from the removal of other organs. Firstly, there are fewer contra-indications. It can be performed on persons with chronic conditions that would usually exclude them from receiving other organs, such as cancer. As the cornea is not vascularised, the risk of damage is considered to be zero, except in cases of cancers of cerebral neurological origin or melanoma.

Secondly, the donor's remains can be preserved for up to 24 hours after death. This makes it possible to recruit care services that are not usually involved in organ transplants, as these services provide new potential donor recruitment resources. This includes palliative care units.

There is currently no French literature on corneal donation specifically in palliative care units. There is a lack of data on the factors that encourage or hinder donation.

Based on our experience of corneal donation in our palliative care unit since 2020, the investigators are conducting a clinical study to evaluate the factors that facilitate or impede corneal donation in our hospital palliative care unit.

02

Conditions studied

  • Corneal Transplantation
  • Corneal Diseases
  • Corneal Donation

Browse trials for

Keywords

  • Tissue donation
  • Corneal transplantation
  • Palliative care unit
03

In context

Corneal Diseases

136 studies on the registry are indexed under Corneal Diseases; 44 are open to participants now.

This study's planned enrollment of 150 is above the median of 112 across 48 observational studies indexed under Corneal Diseases.

Browse Corneal Diseases studies →

Lead sponsor

Groupe Hospitalier Diaconesses Croix Saint-Simon is the lead sponsor of 27 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The source population concerned by this study corresponds to the relatives of the deceased person who has been treated in the palliative care unit, limited to 3 relatives.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Relative or confidant over 18 years of age.
  2. Relative or confidant has received written and oral information on the conditions for participation in this study.
  3. Relative or confidant has signed an informed consent form.

Exclusion criteria

Exclusion Criteria:

  1. Confidant person who does not speak or read French.
  2. Confidant person with a sensory deficit that makes it impossible to carry out an interview.
  3. Confidant person under protective supervision (guardianship, curatorship, or safeguard of justice.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Relatives agree for the corneal donation
  • Relatives disagree for the corneal donation
06

What researchers measure

Primary outcomes

  1. Biographical, Care Experience, and Organ donation attitude characteristics as assessed by structured questionnaires.

    Data collected include biographical and social characteristics of the relative, perceived quality of care in the palliative care unit, experience of being approached regarding corneal donation, and attitudes toward organ and tissue donation.

    Time frame: Enrolment visit and/or month 3

Secondary outcomes

  1. Relatives' perceptions of Cornea Donation Requests following death in the Palliative Care Unit assessed by semi-structured interview.

    Time frame: Enrolment visit and/or month 3

  2. Perceptions of Corneal donation following death in a Palliative Care Unit assessed by structured questionnaire.

    Perceptions and experiences related to corneal donation when death occurs in a palliative care unit, including factors facilitating or hindering consent to donation, assessed through a structured questionnaire administered to relatives of deceased patients.

    Time frame: Enrolment visit and/or month 3

  3. Questionnaire-Based characteristics of relatives opposed and not opposed to Corneal Donation.

    Comparison of demographic characteristics, care experience, and attitudes toward organ and tissue donation between relatives opposed and not opposed to corneal donation, assessed by a structured questionnaire.

    Time frame: Month 39

07

Study locations

1 of 1 sites recruiting
  • Groupe Hospitalier Diaconesses Croix Saint-Simon
    Paris, Paris 75012, France
    • Djazia BOUZELMAT, Clinical Research Assistant · Contact · dbouzelmat@hopital-dcss.org · 0144643098
    • Roger THAY, Doctor · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07868198
Lead sponsor
Groupe Hospitalier Diaconesses Croix Saint-Simon
Responsible party
Roger THAY (Principal Investigator, Groupe Hospitalier Diaconesses Croix Saint-Simon) — Principal investigator
First posted
Oct 9, 2026
Start date
Feb 27, 2025
Primary completion
Dec 31, 2027 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Oct 9, 2026

Study contacts

Djazia BOUZELMAT, Clinical Research Assistant
Contact
dbouzelmat@hopital-dcss.org
0144643098
Roger THAY, Doctor
principal investigator · Groupe Hospitalier Diaconesses Croix Saint-Simon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion